It's been a while! Season 3 update from Surani

Update: 2025-07-02

Description

In this bonus episode, Surani shares an honest update on what’s been happening behind the scenes at Raising Biotech, why Season 3 took longer than planned, and what to expect going forward. From reflections on building the podcast solo to plans for the future, it’s a candid check-in for listeners who’ve been waiting patiently — and a thank you to everyone who’s supported the journey so far.

Support Raising Biotech via the Patreon Page.

Comments

In Channel

S2, E6: iOmx and shaking up the immuno-oncology field with CEO Apollon Papadimitriou, Professor Phillip Beckhove (RCI) and Jared Holz (Mizuho)

2024-06-1833:23

S2, E5: Cerevance and a new approach to Parkinson's disease with CEO Craig Thompson and CNS expert Prof Karl Kieburtz (URMC, Clintrex)

2024-06-1132:56

S2, E4: Sparrow Pharmaceuticals and tackling the ravaging effects of steroids with founder David Katz and experts Dr Peter Merkel (UPenn), Dr Leon Henderson-MacLennan (InThought)

2024-06-0434:35

S2, E3: Ray Therapeutics leveraging optogenetics to tackle vision loss with CEO Paul Bresge and Dr José-Alain Sahel (University of Pittsburgh)

2024-05-2833:51

S2, E2: Fauna Bio tapping animal evolution and AI for drug development with CEO Ashley Zehnder and Prof Elinor Karlsson, Broad Institute (MIT/Harvard)

2024-05-2133:50

S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho

2024-05-1433:35

S1, E6: Alltrna and tRNA therapeutics for rare genetic diseases with CEO Michelle Werner and rare diseases expert Dr David Weinstein

2023-12-1930:09

S1, E5: Arialys and a neuropsychiatry drug revival with CEO Jay Lichter and experts Marty Jefson (Pinteon) and Dr Leon Henderson-MacLennan (InThought)

2023-12-1229:55

S1, E4: Synchron and breakthrough brain implants with CEO Dr Tom Oxley, CCO Kurt Haggstrom and experts Dr Elad Levy (UB), Dr David Putrino (Mount Sinai)

2023-12-0533:51

S1, E3: eGenesis and xenotransplantation with CEO Mike Curtis and Dr Adam Griesemer, NYU

2023-11-2831:27

S1, E2: Ochre Bio with CEO/Co-founder Jack O'Meara and liver expert Dr Scott Friedman, Mount Sinai

2023-11-2131:07

S1, E1: Empress Therapeutics with CEO/Co-founder Jason Park + experts Prof Jim Collins, MIT and Dr Leon Henderson-MacLennan, InThought

2023-11-2131:54

S3, EP5: Special Analysis: What's going on with European Biotech? - Reporting from BioEurope in Vienna

2025-11-0518:32

S3, E4: ReproNovo’s strategic trash-to-treasure bet on fertility and reproductive health - with CEO Jean Marie Duval

2025-10-0131:30

S3, E3: AltruBio’s Cinderella story from bankruptcy talks to a $225M Series B to tackle autoimmune diseases - with CEO Dr Judy Chou

2025-09-0332:14

S3, E2: The Biotech Bromance: Serial CEO and Investor’s 20‑Year Journey of Building Biotechs with Steve Butts, Arrivo Bio and Dave Adair, Solas BioVentures

2025-08-0633:29

S3, E1: How Xaira Therapeutics went from incubation to a billion dollar launch - with Vik Bajaj, CEO Foresite Labs

2025-07-0229:28

It's been a while! Season 3 update from Surani

2025-07-0206:36